Target Price | $66.10 |
Price | $50.07 |
Potential |
32.02%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Gemini Therapeutics Inc 2025 .
The average Gemini Therapeutics Inc target price is $66.10.
This is
32.02%
register free of charge
$85.00
69.76%
register free of charge
$40.00
20.11%
register free of charge
|
|
A rating was issued by 10 analysts: 9 Analysts recommend Gemini Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Gemini Therapeutics Inc stock has an average upside potential 2025 of
32.02%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.42 | -4.34 |
92.41% | 26.90% | |
P/E | negative |
5 Analysts have issued a Gemini Therapeutics Inc forecast for earnings per share. The average Gemini Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Gemini Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.